Contact Information
Company Information
Company
Verve Therapeutics
Annual Revenue
32330000.0
Technologies
Outlook
Microsoft Office 365
WP Engine
Adobe Marketing Cloud
Mobile Friendly
Nginx
New Relic
Varnish
Google Analytics
Google Tag Manager
Remote
AI
Keywords
biotechnology: pharmaceutical preparations
health care
biotechnology research
gene editing
cardiovascular disease
cvd
atherosclerotic cardiovascular disease
ascvd
pcsk9 gene
ldl-c lowering
single-course therapy
in vivo gene editing
galnac-lnp
lipid nanoparticles
genetic targets
clinical trials
familial hypercholesterolemia
gene therapy
biomedicine
live-cell delivery
rna technology
messenger rna
grna
base editing
crispr technology
medical innovation
healthcare access
clinical pipeline
patient adherence
chronic care model
therapeutic approach
cost-effective medicine
long-term health outcomes
life expectancy
heart attack prevention
vascular health
public health impact
scientific research
genetics & health
dialing down cholesterol
cholesterol management
biopharmaceutical development
genetic resistance
healthcare infrastructure
medical breakthroughs
patient care
health intervention
safety profile
efficacy of treatments
drug delivery systems
biomedical research
healthcare professionals
ldl cholesterol
coronary artery disease
innovative therapies
genetic medicines
single-course treatment
pcsk9
angptl3
lpa
biotechnology
pharmaceuticals
research & development
patient outcomes
transformative therapies
genetic disorders
refractory hypercholesterolemia
heart disease prevention
durable solutions
healthcare innovation
fast track designation
clinical-stage biotechnology
cardiovascular risk
genetic medicine
precision medicine
health technology
health
wellness & fitness
hospital & health care
medical
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans